PT3042658T - Composição medicinal que melhora a resistência à leptina - Google Patents
Composição medicinal que melhora a resistência à leptinaInfo
- Publication number
- PT3042658T PT3042658T PT14843063T PT14843063T PT3042658T PT 3042658 T PT3042658 T PT 3042658T PT 14843063 T PT14843063 T PT 14843063T PT 14843063 T PT14843063 T PT 14843063T PT 3042658 T PT3042658 T PT 3042658T
- Authority
- PT
- Portugal
- Prior art keywords
- medicinal composition
- leptin resistance
- composition improving
- improving leptin
- resistance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
- C07C245/02—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides
- C07C245/06—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings
- C07C245/10—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013183265 | 2013-09-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT3042658T true PT3042658T (pt) | 2019-05-13 |
Family
ID=52628448
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT14843063T PT3042658T (pt) | 2013-09-04 | 2014-09-03 | Composição medicinal que melhora a resistência à leptina |
Country Status (8)
Country | Link |
---|---|
US (1) | US9931351B2 (pt) |
EP (1) | EP3042658B1 (pt) |
JP (1) | JP6378685B2 (pt) |
DK (1) | DK3042658T3 (pt) |
ES (1) | ES2708577T3 (pt) |
PL (1) | PL3042658T3 (pt) |
PT (1) | PT3042658T (pt) |
WO (1) | WO2015033981A1 (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20210145808A1 (en) * | 2018-04-16 | 2021-05-20 | Kyoto University | Composition for Protecting Cardiomyocyte |
JP7101982B2 (ja) | 2018-07-31 | 2022-07-19 | 国立大学法人京都大学 | 脳梗塞の処置用の医薬組成物 |
KR20220087499A (ko) | 2019-10-24 | 2022-06-24 | 고쿠리츠 다이가쿠 호진 교토 다이가쿠 | 연골 보호용의 의약 조성물 |
JP2022170472A (ja) | 2021-04-28 | 2022-11-10 | 国立大学法人京都大学 | 皮膚組織の異常を改善するための組成物 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69332105T2 (de) | 1992-09-29 | 2003-03-06 | Inhale Therapeutic Systems San | Pulmonale abgabe von aktiven fragmenten des parathormons |
KR19990077319A (ko) | 1996-01-17 | 1999-10-25 | 한센 핀 베네드, 안네 제헤르 | 축합된 1,2,4-티아디아진 및 축합된 1,4-티아진 유도체, 그것의제조방법 및 사용 |
WO1999003861A1 (en) | 1997-07-16 | 1999-01-28 | Novo Nordisk A/S | Fused 1,2,4-thiadiazine derivatives, their preparation and use |
US6440961B1 (en) * | 1997-10-27 | 2002-08-27 | Dr. Reddy's Research Foundation | Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
US8273700B2 (en) * | 2005-09-29 | 2012-09-25 | The Johns Hopkins University | Methods and compositions for treatment of cystic fibrosis |
US9573887B2 (en) * | 2010-07-30 | 2017-02-21 | Daito Chemix Corporation | Naphthalene derivative |
ES2574832T3 (es) | 2010-09-30 | 2016-06-22 | Kyoto University | Agente para el tratamiento de enfermedades oculares |
KR101862912B1 (ko) * | 2012-07-20 | 2018-05-30 | 클리브 바이오사이언스 인코포레이티드 (클리브) | p97 복합체의 저해제로서의 축합된 피리미딘 |
US9782420B2 (en) | 2013-02-20 | 2017-10-10 | Kyoto University | Method for treating eye diseases |
-
2014
- 2014-09-03 EP EP14843063.0A patent/EP3042658B1/en active Active
- 2014-09-03 JP JP2015535505A patent/JP6378685B2/ja active Active
- 2014-09-03 WO PCT/JP2014/073256 patent/WO2015033981A1/ja active Application Filing
- 2014-09-03 DK DK14843063.0T patent/DK3042658T3/en active
- 2014-09-03 PT PT14843063T patent/PT3042658T/pt unknown
- 2014-09-03 ES ES14843063T patent/ES2708577T3/es active Active
- 2014-09-03 PL PL14843063T patent/PL3042658T3/pl unknown
- 2014-09-03 US US14/916,085 patent/US9931351B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3042658A4 (en) | 2017-03-29 |
DK3042658T3 (en) | 2019-04-23 |
PL3042658T3 (pl) | 2019-08-30 |
US20160303144A1 (en) | 2016-10-20 |
JP6378685B2 (ja) | 2018-08-22 |
US9931351B2 (en) | 2018-04-03 |
ES2708577T3 (es) | 2019-04-10 |
EP3042658A1 (en) | 2016-07-13 |
WO2015033981A1 (ja) | 2015-03-12 |
EP3042658B1 (en) | 2019-01-16 |
JPWO2015033981A1 (ja) | 2017-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1223975A1 (zh) | 含納米氣泡的組合物及其用途 | |
HK1216175A1 (zh) | 治療性化合物和組合物 | |
IL286759A (en) | Therapeutic methods and preparations | |
IL246377A0 (en) | Pharmaceutical preparations for oral administration | |
EP2889350A4 (en) | ADHESIVE COMPOSITION | |
GB201317286D0 (en) | Composition and Use | |
HK1220920A1 (zh) | 治療性組合物和其用途 | |
HK1215191A1 (zh) | 低劑量醫藥組合物 | |
IL241254A0 (en) | Pharmaceutical preparations containing everolimus | |
EP3006525A4 (en) | ASPHALT-URETHANE COMPOSITION | |
HK1215678A1 (zh) | 口腔用組合物 | |
HK1225306A1 (zh) | 牙科組合物 | |
EP3066178A4 (en) | GREASE COMPOSITION | |
SG11201601477VA (en) | Pharmaceutical composition | |
HK1219691A1 (zh) | 醫藥組成物及其用途 | |
PT3042658T (pt) | Composição medicinal que melhora a resistência à leptina | |
GB201301979D0 (en) | New composition and use thereof | |
SG11201506778QA (en) | Plasticizing composition | |
GB201308933D0 (en) | Paediatric composition | |
EP2977051A4 (en) | GINSENOSIDZUSAMMENSETZUNG | |
GB201301774D0 (en) | Composition | |
HK1220143A1 (zh) | 藥物組合物 | |
EP2956112A4 (en) | DENTAL COMPOSITION | |
GB201318813D0 (en) | Dental composition | |
GB201304625D0 (en) | New pharmaceutical composition |